Polymerase Chain Reaction Market 2023-2030: Comprehensive Industry Overview and Growth Prospects The global polymerase chain reaction (PCR) market size reached USD 31.5 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 8.5% during the forecast period. Polymerase chain reaction is a widely recognized and efficient technique used to duplicate specific sections of DNA for further analysis in various fields such as clinical infectious illness diagnosis, nucleic acid amplification, paternity testing, and DNA fingerprinting. Access Full Report: https://www.fairfieldmarketresearch.com/report/polymerase-chain-
reaction-market
The market is primarily driven by the growing geriatric population, the increasing number of hospitals, and the rise in infectious diseases. Moreover, advancements in technology, the growing acceptance of personalized medicine, and awareness of advanced procedures have also contributed to the market's growth. The COVID-19 pandemic further accelerated the market, as PCR techniques were extensively used for the detection of SARS-CoV-2 infection, leading to an exponential growth in 2020 and 2021. Technological advancements and the introduction of innovative PCR tests have played a significant role in driving market growth. For instance, F. Hoffmann-La Roche Ltd. received approval from the US Food and Drug Administration for the Cobas SARS-CoV-2 nucleic acid test, facilitating the detection of asymptomatic and symptomatic cases in point-of-care settings. Many other companies have also received global approval for their PCR assays for the identification of SARS-CoV-2 infection. Despite the favorable impact of the pandemic on the PCR market, declining demand for COVID-19-related disorders is expected to restrain market growth in the coming years. However, the rising number of infectious diseases, chronic and genetic disorders, and the need for molecular diagnostic techniques for reliable diagnoses are likely to drive up demand during the forecast period.